Prevalence and characteristics of anti-factor B and anti-C3 autoantibodies in a cohort of C3 glomerulopathy and membranoproliferative glomerulonephritis type I

被引：0
|
作者：
Marinozzi, Maria Chiara [1 ]
Roumenina, Lubka [1 ]
Chauvet, Sophie [1 ]
Dragon-Durey, Marie Agnes [1 ,2 ]
Fremeaux-Bacchi, Veronique [1 ,2 ]
Le Quintrec, Moglie [1 ]
机构：
[1] INSERM, Cordeliers Res Ctr, UMRS 872, Paris, France
[2] Hop Europeen Georges Pompidou, Dept Immunol, Paris, France
来源：
MOLECULAR IMMUNOLOGY | 2015年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
115
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [31] IgM autoantibodies to complement factor H in C3 glomerulopathy
    Cugno, Massimo
    Mancuso, Maria Cristina
    Depetri, Federica
    Peyvandi, Flora
    Ardissino, Gianluigi
    JOURNAL OF NEPHROLOGY, 2024, 37 (05) : 1415 - 1416
  • [32] ALTERATION OF C3 NEPHRITIC FACTOR IN A PATIENT WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS TYPE-II
    SEINO, J
    NARITA, M
    NOSHIRO, H
    SATO, K
    SATO, H
    SAITO, T
    ABE, K
    NEPHRON, 1995, 69 (01): : 114 - 115
  • [33] Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report
    Deshayes, Samuel
    Silva, Nicolas Martin
    Chatelet, Valerie
    Chantepie, Sylvain
    Le Quintrec, Moglie
    Comoz, Francois
    Bridoux, Frank
    Dragon-Durey, Marie-Agnes
    Aouba, Achille
    CLINICAL RHEUMATOLOGY, 2018, 37 (04) : 1119 - 1122
  • [34] THE NATIONAL STUDY OF MEMBRANOPROLIFERATIVE GLOMERULONEPHRTIS AND C3 GLOMERULOPATHY - CHARACTERISATION OF THE PAEDIATRIC COHORT
    Wong, Edwin K. S.
    Marchbank, Kevin
    Pappworth, Isabel
    Walters, Rebecca
    Lomax-Browne, Hannah
    Harris, Claire
    Morgan, Paul
    Pickering, Matthew
    Goodship, Tim H. J.
    Malcomson, Roger
    Cook, Terry
    Johnson, Sally
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [35] Eculizumab reversed severe distal ischemic syndrome and glomerulonephritis with isolated C3 deposits associated with anti-factor H autoantibodies: a case report
    Samuel Deshayes
    Nicolas Martin Silva
    Valérie Chatelet
    Sylvain Chantepie
    Moglie Le Quintrec
    François Comoz
    Frank Bridoux
    Marie-Agnès Dragon-Durey
    Achille Aouba
    Clinical Rheumatology, 2018, 37 : 1119 - 1122
  • [36] UTILIZATION OF PROPERDIN BY C3 NEPHRITIC FACTOR IN PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
    SPITZER, R
    STITZEL, A
    PEDIATRIC RESEARCH, 1974, 8 (04) : 461 - 461
  • [37] NON-IMMUNOGLOBULIN C3 ACTIVATING FACTOR IN MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
    BARTLOW, BG
    ROBERTS, JL
    LEWIS, EJ
    KIDNEY INTERNATIONAL, 1978, 14 (06) : 706 - 706
  • [38] INVIVO ABROGATION OF SERUM C3 AND C5 BY ADMINISTRATION OF COBRA VENOM FACTOR AND HETEROLOGOUS ANTI-C3
    DRAKE, WP
    POKORNEY, DR
    MARDINEY, MR
    JOURNAL OF IMMUNOLOGICAL METHODS, 1974, 6 (1-2) : 61 - 72
  • [39] Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy
    Kovala, Marja
    Seppala, Minna
    Raisanen-Sokolowski, Anne
    Meri, Seppo
    Honkanen, Eero
    Kaartinen, Kati
    CELLS, 2023, 12 (05)
  • [40] Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series
    Sparta, Giuseppina
    Gaspert, Ariana
    Neuhaus, Thomas J.
    Weitz, Marcus
    Mohebbi, Nilufar
    Odermatt, Urs
    Zipfel, Peter F.
    Bergmann, Carsten
    Laube, Guido F.
    CLINICAL KIDNEY JOURNAL, 2018, 11 (04) : 479 - 490
12345